View in EDS HTML Full Text PDF Full Text

Safety and immunogenicity of a tetravalent dengue vaccine (CYD-TDV) in HIV-positive adults aged 18-50 years in Brazil: Results from a phase II, randomized, observer-blind, placebo-controlled trial.

Saved in:
Bibliographic Details
Title: Safety and immunogenicity of a tetravalent dengue vaccine (CYD-TDV) in HIV-positive adults aged 18-50 years in Brazil: Results from a phase II, randomized, observer-blind, placebo-controlled trial.
Authors: Perroud A; Global Clinical Development Strategy, Sanofi, São Paulo, Brazil., Madruga JVR; Centro de Referência e Treinamento DST/AIDS, São Paulo, Brazil., Fernandes L; Aids and Molecular Immunology Laboratory, Hospital Geral de Nova Iguaçu & IOC/Fiocruz, Rio de Janeiro, Brazil., Luz K; Instituto de Medicina Tropical da Universidade Federal do Rio Grande do Norte, Natal, Brazil., Lukic N; IQVIA (on behalf of Sanofi), Belgrade, Serbia., Bourée S; IVIDATA Life Sciences (on behalf of Sanofi), Lyon, France., Sanchez-Ruiz M; Global Clinical Study Management, Sanofi, Ciudad de Mexico, Mexico., Pegoraro F; Global Clinical Study Management, Sanofi, São Paulo, Brazil., Petit C; Global Immunology, Sanofi, Marcy-l'Étoile, France., Zambrano B; Global Clinical Development Strategy, Sanofi, Montevideo, Uruguay., Dayan G; Global Clinical Development Strategy, Sanofi, Swiftwater, PA, USA.
Source: Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2025 Dec; Vol. 21 (1), pp. 2582237. Date of Electronic Publication: 2025 Nov 10.
Publication Type: Journal Article; Clinical Trial, Phase II; Randomized Controlled Trial
Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101572652 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2164-554X (Electronic) Linking ISSN: 21645515 NLM ISO Abbreviation: Hum Vaccin Immunother Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41213642
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Safety and immunogenicity of a tetravalent dengue vaccine (CYD-TDV) in HIV-positive adults aged 18-50 years in Brazil: Results from a phase II, randomized, observer-blind, placebo-controlled trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Perroud+A%22">Perroud A</searchLink>; Global Clinical Development Strategy, Sanofi, São Paulo, Brazil.<br /><searchLink fieldCode="AU" term="%22Madruga+JVR%22">Madruga JVR</searchLink>; Centro de Referência e Treinamento DST/AIDS, São Paulo, Brazil.<br /><searchLink fieldCode="AU" term="%22Fernandes+L%22">Fernandes L</searchLink>; Aids and Molecular Immunology Laboratory, Hospital Geral de Nova Iguaçu & IOC/Fiocruz, Rio de Janeiro, Brazil.<br /><searchLink fieldCode="AU" term="%22Luz+K%22">Luz K</searchLink>; Instituto de Medicina Tropical da Universidade Federal do Rio Grande do Norte, Natal, Brazil.<br /><searchLink fieldCode="AU" term="%22Lukic+N%22">Lukic N</searchLink>; IQVIA (on behalf of Sanofi), Belgrade, Serbia.<br /><searchLink fieldCode="AU" term="%22Bourée+S%22">Bourée S</searchLink>; IVIDATA Life Sciences (on behalf of Sanofi), Lyon, France.<br /><searchLink fieldCode="AU" term="%22Sanchez-Ruiz+M%22">Sanchez-Ruiz M</searchLink>; Global Clinical Study Management, Sanofi, Ciudad de Mexico, Mexico.<br /><searchLink fieldCode="AU" term="%22Pegoraro+F%22">Pegoraro F</searchLink>; Global Clinical Study Management, Sanofi, São Paulo, Brazil.<br /><searchLink fieldCode="AU" term="%22Petit+C%22">Petit C</searchLink>; Global Immunology, Sanofi, Marcy-l'Étoile, France.<br /><searchLink fieldCode="AU" term="%22Zambrano+B%22">Zambrano B</searchLink>; Global Clinical Development Strategy, Sanofi, Montevideo, Uruguay.<br /><searchLink fieldCode="AU" term="%22Dayan+G%22">Dayan G</searchLink>; Global Clinical Development Strategy, Sanofi, Swiftwater, PA, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101572652%22">Human vaccines & immunotherapeutics</searchLink> [Hum Vaccin Immunother] 2025 Dec; Vol. 21 (1), pp. 2582237. <i>Date of Electronic Publication: </i>2025 Nov 10.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Clinical Trial, Phase II; Randomized Controlled Trial
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101572652 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2164-554X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221645515%22">21645515 </searchLink><i>NLM ISO Abbreviation: </i>Hum Vaccin Immunother <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41213642
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1080/21645515.2025.2582237
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2582237
    Titles:
      – TitleFull: Safety and immunogenicity of a tetravalent dengue vaccine (CYD-TDV) in HIV-positive adults aged 18-50 years in Brazil: Results from a phase II, randomized, observer-blind, placebo-controlled trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Perroud A
      – PersonEntity:
          Name:
            NameFull: Madruga JVR
      – PersonEntity:
          Name:
            NameFull: Fernandes L
      – PersonEntity:
          Name:
            NameFull: Luz K
      – PersonEntity:
          Name:
            NameFull: Lukic N
      – PersonEntity:
          Name:
            NameFull: Bourée S
      – PersonEntity:
          Name:
            NameFull: Sanchez-Ruiz M
      – PersonEntity:
          Name:
            NameFull: Pegoraro F
      – PersonEntity:
          Name:
            NameFull: Petit C
      – PersonEntity:
          Name:
            NameFull: Zambrano B
      – PersonEntity:
          Name:
            NameFull: Dayan G
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 12
              Text: 2025 Dec
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2164-554X
          Numbering:
            – Type: volume
              Value: 21
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Human vaccines & immunotherapeutics
              Type: main
ResultId 1